The use of proton nuclear magnetic resonance spectrometry (1H NMR) for monitoring the reaction of epoxides with butylamine and predictive capabilities of the relative alkylation index (RAI) for skin sensitization by epoxides
Roberts, D.W.
Toxicology and Applied Pharmacology 112(2): 331-332
1992
ISSN/ISBN: 0041-008X PMID: 1539170 Document Number: 396958
Document emailed within 1 workday
Related Documents
Day, B.W.; Naylor, S.; Gan, L.S.; Sahali, Y.; Nguyen, T.T.; Skipper, P.L.; Wishnok, J.S.; Tannenbaum, S.R. 1990: Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts Cancer Research 50(15): 4611-4618Ong, R.L.; Pittman, C.S. 1985: Proton nuclear magnetic resonance assignments of thyroid hormone and its analogues Biochemistry International 10(5): 803-811
Vion-Dury, J.; Salvan, A.M.; Cozzone, P.J. 1999: Proton magnetic resonance spectrometry for the non-invasive exploration of human brain metabolism: current and future clinical applications Revue Neurologique (Paris) 155(11): 903-926
Mountford, C.E.; Grossman, G.; Reid, G.; Fox, R.M. 1982: Characterization of transformed cells and tumors by proton nuclear magnetic resonance spectroscopy Cancer Research 42(6): 2270-2276
Rokitianskiĭ, V.I.; Iakimov, I.V. 1971: Study of proton relaxation in articular tissues following trauma according to nuclear magnetic resonance data Ortopediia Travmatologiia i Protezirovanie 32(9): 35-41
Zhang, C.-Y.; Zhang, N.; He, L. 2014: Quantitative determination of bosentan by proton nuclear magnetic resonance with internal standard method Yao Xue Xue Bao 49(2): 249-251
O'hara, K.; Shiomi, Y.; Kono, M. 1983: Comparative study of the activities of beta lactamase inhibitors by nuclear magnetic resonance spectrometry Japanese Journal of Antibiotics 36(10): 2763-2768
O'Hara, K. 1994: Application of nuclear magnetic resonance spectrometry to measure the activity of bacterial macrolide esterase Microbios 79(321): 231-239
Hanna, G.M. 1995: Determination of ephedrine, pseudoephedrine, and norephedrine in mixtures (bulk and dosage forms) by proton nuclear magnetic resonance spectroscopy Journal - Association of Official Analytical Chemists 78(4): 946-954
de Certaines, J.D.; Nadal, L.; Leray, G.; Serrai, H.; Lewa, C.J. 1996: Proton nuclear magnetic resonance spectroscopy of plasma lipoprotein: technical problems and potential interest in cancer disease Anticancer Research 16(3b): 1451-1460
Nadal, L.; Leray, G.; Desbarats, C.; Darcel, F.; Bansard, J.Y.; Bondon, A.; de Certaines, J.D. 1997: Proton and phosphorus nuclear magnetic resonance spectroscopy of human brain tumor extracts with automatic data classification: a preliminary study Cellular and Molecular Biology 43(5): 659-673
Slaga, T.J.; Bracken, W.J.; Gleason, G.; Levin, W.; Yagi, H.; Jerina, D.M.; Conney, A.H. 1979: Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo(a)pyrene 7,8-diol-9,10-epoxides Cancer Research 39(1): 67-71
Lorenz, R.; Hedde, J.P.; Diehl, V. 1993: Can nuclear magnetic resonance tomography supplement and expand splenic diagnosis in malignant systemic diseases? Comparison of nuclear magnetic resonance tomography, ultrasound and computerized tomography findings Medizinische Klinik 88(3): 125-128
Dupin, J.P.; Casadebaig, F.; Pometan, J.P.; Petraud, M.; Barbe, B.; Moulines, J. 1979: The Sakaguchi reaction. III. Structural study by nuclear magnetic resonance of coloured compounds Annales Pharmaceutiques Francaises 37(11-12): 523-530
Abel, M.; Friedburg, H. 1987: Medication and monitoring in young pediatric patients in NMR (nuclear magnetic resonance) studies Der Anaesthesist 36(3): 137-139
Fiegler, W.; Felix, R.; Schörner, W.; Köhler, D. 1985: Diagnosis of kidney diseases with magnetic resonance tomography including the use of nuclear magnetic resonance contrast media Der Urologe. Ausg. a 24(5): 264-269
Poptani, H.; Puumalainen, A.M.; Gröhn, O.H.; Loimas, S.; Kainulainen, R.; Ylä-Herttuala, S.; Kauppinen, R.A. 1998: Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging Cancer Gene Therapy 5(2): 101-109
Rumbach, L.; Caires, M.C.; Warter, J.M.; Collard, M.; Scheiber, C.; Gounot, D.; Dumitresco, B.; Chambron, J. 1985: Contribution to proton nuclear magnetic resonance imaging in multiple sclerosis. Contribution of a multiple spin echo sequence Revue Neurologique (Paris) 141(8-9): 583-586
Nédélec, L. 1970: Epoxides of 5(10), 9(11)-estradienes Bulletin de la Societe Chimique de France (7): 2548-2556
Hecht, S.S.; Amin, S.; Huie, K.; Melikian, A.A.; Harvey, R.G. 1987: Enhancing effect of a bay region methyl group on tumorigenicity in newborn mice and mouse skin of enantiomeric bay region diol epoxides formed stereoselectively from methylchrysenes in mouse epidermis Cancer Research 47(20): 5310-5315